DIMENSIONAL FUND ADVISORS LP - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 114 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q3 2020$16,049,000
-15.5%
303,785
-2.0%
0.01%
-12.5%
Q2 2020$18,988,000
+8.1%
309,866
-0.2%
0.01%
-11.1%
Q1 2020$17,560,000
-2.2%
310,424
-1.6%
0.01%
+28.6%
Q4 2019$17,961,000
+8.1%
315,448
+1.6%
0.01%
+16.7%
Q3 2019$16,611,000
-10.6%
310,362
-0.2%
0.01%
-14.3%
Q2 2019$18,575,000
-1.9%
311,088
+2.4%
0.01%
-12.5%
Q1 2019$18,928,000
+8.0%
303,660
+5.0%
0.01%0.0%
Q4 2018$17,528,000
+6.6%
289,243
+2.9%
0.01%
+33.3%
Q3 2018$16,442,000
+35.1%
281,111
+3.6%
0.01%
+20.0%
Q2 2018$12,168,000
+1.8%
271,262
+0.6%
0.01%0.0%
Q1 2018$11,956,000
+1.6%
269,650
-0.7%
0.01%0.0%
Q4 2017$11,764,000
-6.2%
271,493
+0.7%
0.01%0.0%
Q3 2017$12,540,000
-4.7%
269,554
+1.5%
0.01%
-16.7%
Q2 2017$13,154,000
-2.9%
265,676
+7.5%
0.01%0.0%
Q1 2017$13,541,000
+6.0%
247,114
+7.8%
0.01%0.0%
Q4 2016$12,774,000
+40.5%
229,340
+15.2%
0.01%
+20.0%
Q3 2016$9,094,000
+27.7%
199,130
+11.7%
0.01%
+25.0%
Q2 2016$7,119,000
+15.8%
178,251
+1.0%
0.00%0.0%
Q1 2016$6,147,000
-15.3%
176,529
+4.5%
0.00%
-20.0%
Q4 2015$7,257,000
+5.9%
168,874
+7.3%
0.01%
+25.0%
Q3 2015$6,854,000
+1.4%
157,418
+20.1%
0.00%0.0%
Q2 2015$6,761,000
+47.3%
131,022
+11.8%
0.00%
+33.3%
Q1 2015$4,590,000
+20.3%
117,230
+18.7%
0.00%0.0%
Q4 2014$3,814,000
+49.9%
98,755
+37.0%
0.00%
+50.0%
Q3 2014$2,545,000
+43.4%
72,094
+9.5%
0.00%
+100.0%
Q2 2014$1,775,000
+23.3%
65,834
+18.6%
0.00%0.0%
Q1 2014$1,439,000
+35.5%
55,521
+13.3%
0.00%0.0%
Q4 2013$1,062,000
+28.9%
49,012
+15.8%
0.00%0.0%
Q3 2013$824,000
+18.9%
42,317
-4.7%
0.00%0.0%
Q2 2013$693,00044,4170.00%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q3 2020
NameSharesValueWeighting ↓
UBS ASSET MANAGEMENT AMERICAS INC 2,300$203,550,0000.00%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders